# US 2011/0237562 A1 · Use of a container of an inorganic additive containing plastic material

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0237562 A1
- Document ID: US20110237562A1
- Status: Published application
- Kind: A1
- Application number: 13/152,882
- Filed: 2011-06-03
- Published: 2011-09-29
- Earliest claimed: 2004-12-28
- Assignees: Udo Mattern
- Inventors: Claudia MATTERN
- Web page: https://patentgrep.com/patent/US20110237562A1

## CPC

- B65D 1/0207: {characterised by material, e.g. composition, physical features}
- A61P 5/26: Androgens
- A61J 1/14: Details; Accessories therefor (A61J7/00 takes precedence; openers B65D, B67B7/00)
- B65D: CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE

## Abstract

The present invention relates to the use of a container, made of an inorganic additive containing plastic material, for reducing physical/chemical interaction between the container and an oil, fat and/or wax containing formulation contained therein.

## Claims

### Claim at position 1

1-12. (canceled)

### Claim 13

A method for reducing physical/chemical interaction between a plastic container and a lipophilic testosterone gel formulation, comprising:
(a) adding an inorganic additive to a plastic material during manufacture; and
(b) exposing the plastic container to the formulation;
wherein the lipophilic testosterone gel formulation comprises testosterone and at least one oil, fat, wax, lipophilic or partially lipophilic carrier; and a compound or a mixture of compounds having surface tension decreasing activity, in an amount effective for in situ generation of an emulsion upon contact of the formulation with water; and
wherein the lipophilic testosterone gel formulation is used for mammalian nasal application.

### Claim 14 (depends on 13)

The method according to claim 13 wherein the physical/chemical interaction is an adsorption of the formulation to the plastic material.

### Claim 15 (depends on 13)

The method according to claim 13, wherein the inorganic additive is at least a pigment.

### Claim 16 (depends on 15)

The method according to claim 15, wherein said pigment is selected from the group consisting of titanium dioxide (TiO2), surface-treated titanium dioxide, or a mixture thereof

### Claim 17 (depends on 13)

The method according to claim 13, wherein the additive is present in the plastic material in an amount between about 0.1 and about 10% by weight based on the weight of the plastic material.

### Claim 18 (depends on 13)

The method according to claim 13, wherein the plastic material comprises polyolefin.

### Claim 19 (depends on 18)

The method according to claim 18, wherein the polyolefin is selected from the group of polyethylene, polypropylene, copolymers of ethylene and propylene, or a mixture thereof.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the plastic material comprises low density polyethylene (LDPE).

### Claim 21 (depends on 13)

The method according to claim 13, wherein the plastic material is suitable for extrusion blow molding.

### Claim 22 (depends on 13)

The method according to claim 13, wherein the additive is present in the plastic material in an amount between about 0.1% to about 5% by weight based on the weight of the plastic material.

### Claim 23 (depends on 13)

The method according to claim 13, wherein the additive is present in the plastic material in an amount of about 2% by weight based on the weight of the plastic material.

### Claim 24 (depends on 13)

The method of claim 13, wherein the plastic container extends the shelf life and stability of the formulation for a period of time longer than that of a plastic container without the addition of the inorganic additive.

### Claim 25

A method for reducing physical or chemical interaction between a plastic container and a lipophilic testosterone gel formulation, comprising:
(a) adding to a plastic material comprising polyolefin titanium dioxide (TiO2) in an amount between about 0.1 and about 10% by weight, based on the weight of the plastic material; and
(b) exposing the plastic container to the formulation;
wherein the lipophilic formulation comprises (i) at least one steroid hormone dissolved or suspended in an oil, fat, wax, lipophilic or partially lipophilic carrier, and (ii) a compound or a mixture of compounds having surface tension decreasing activity, in an amount effective for in situ generation of an emulsion upon contact of the formulation with water;
wherein the formulation is used for mammalian nasal application; and
wherein the plastic container extends the shelf life and stability of the formulation for a period of time longer than that of a plastic container without the addition of titanium dioxide (TiO2).

### Claim 26 (depends on 25)

The method according to claim 25, wherein the polyolefin is selected from the group of polyethylene, polypropylene, copolymers of ethylene and propylene and mixtures thereof.

### Claim 27

The method according to 25, wherein the plastic material comprises low density polyethylene (LDPE).

### Claim 28 (depends on 25)

The method according to claim 25, wherein the plastic material is suitable for extrusion blow molding.

### Claim 29 (depends on 25)

The method according to claim 25, wherein the titanium dioxide (TiO2) is surface-treated titanium dioxide.

### Claim 30 (depends on 25)

The method according to claim 25, wherein the titanium dioxide (TiO2) is mixed with surface-treated titanium dioxide.

### Claim 31 (depends on 25)

The method according to claim 25, wherein the titanium dioxide (TiO2) is present in the plastic material in an amount of between about 0.1% to about 5% by weight based on the weight of the plastic material.

### Claim 32 (depends on 25)

The method according to claim 25, wherein the titanium dioxide (TiO2) is present in the plastic material in an amount of about 2% by weight based on the weight of the plastic material.

### Claim 33 (depends on 25)

The method according to claim 25, wherein the amount of the testosterone remaining in the lipophilic testosterone gel formulation after long-term storage is about 100%, wherein the percentage of the remaining drug is determined by high performance liquid chromatography (HPLC) technique.
